Ultrahuman, the smart ring maker and health optimization platform, has launched M2 Live in the U.S. – integrating glucose data from Abbott’s over-the-counter Lingo continuous glucose monitor into its metabolic health platform. Sensors start at $99/month on subscription with no prescription required.
Ultrahuman launched its first CGM product for people without diabetes in 2021. M2 Live builds on that foundation with a clinically validated Metabolic Score (published in Scientific Reports, confirmed across nine clinical centers to differentiate between non-diabetic and pre-diabetic individuals), real-time AI that connects glucose patterns with sleep, HRV, activity, recovery, and skin temperature data from Ultrahuman’s smart ring, and a food scoring system that rates how different foods affect each user’s glucose individually.
Only 1 in 8 U.S. adults is metabolically healthy – a stat that drives the chronic disease burden underlying cardiovascular conditions, type 2 diabetes, and related conditions that disproportionately affect women, particularly during and after the menopause transition as metabolic risk accelerates.
“Ultrahuman created an entirely new category: glucose monitoring for wellness,” said founder and CEO Mohit Kumar. “By combining M2 Live with glucose data from Abbott’s Lingo, people can better understand how to make healthy change and improve their metabolic health.”
